Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zenas BioPharma Inc.

9.69
+0.11001.15%
Post-market: 9.690.00000.00%16:04 EDT
Volume:164.81K
Turnover:1.59M
Market Cap:405.37M
PE:-1.38
High:9.86
Open:9.61
Low:9.41
Close:9.58
Loading ...
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
Jun 04, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2025

Major Issues Report

Form 8-K - Current report
Mar 11, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 11, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 05, 2025

Major Issues Report

Form 8-K - Current report
Dec 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Oct 21, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 25, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 23, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 23, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 23, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 16, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 16, 2024

Major Issues Report

Form 8-K - Current report
Sep 11, 2024

Correspondence

Form CORRESP - Correspondence
Sep 11, 2024

Correspondence

Form CORRESP - Correspondence
Sep 06, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]